2011
DOI: 10.1158/0008-5472.sabcs11-p2-08-03
|View full text |Cite
|
Sign up to set email alerts
|

P2-08-03: Quantitative MRI for Noninvasive Prediction of Prognostic Markers in Breast Cancer.

Abstract: Background: Magnetic resonance imaging (MRI) is a valuable tool for assessing extent of breast cancer and monitoring treatment response. Quantitative measures by diffusion-weighted MRI (DWI) and dynamic contrast-enhanced (DCE) MRI reflect tumor cellularity and vascularity. Tumor grade and some histopathological markers, such as ER, PR, HER-2, Ki67 and P53, are prognostic factors that can also be associated with tumor cellularity and vascularity. DWI and DCE measures may therefore provide a noninvasive means fo… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles